Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer

Clinical trial NCT02790320 · COMPLETED

Trial details

NCT number: NCT02790320
Sponsor: Eisai Farmacêutica S.A.
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Breast Cancer

Start date: 2012-06-01
Primary completion: 2012-10-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.